Net profit of Jubilant Life Sciences declined 94.37% to Rs 5.00 crore in the quarter ended September 2011 as against Rs 88.74 crore during the previous quarter ended September 2010. Sales rose 16.23% to Rs 628.37 crore in the quarter ended September 2011 as against Rs 540.62 crore during the previous quarter ended September 2010.
In the consolidated results, the company reported net profit after minority interest of Rs 79.36 crore in the quarter ended September 2011 as against Rs 73.46 crore during the previous quarter ended September 2010. Sales reported to Rs 1048.08 crore in the quarter ended September 2011 as against Rs 858.97 crore during the previous quarter ended September 2010.
| Particulars | Quarter Ended |
| | Sep. 2011 | Sep. 2010 | % Var. |
| Sales | 628.37 | 540.62 | 16 |
| OPM % | 17.60 | 23.22 | -24 |
| PBDT | 76.91 | 117.49 | -35 |
| PBT | 47.70 | 92.74 | -49 |
| NP | 5.00 | 88.74 | -94 |